Gary Neal Dunetz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Prospect St, Suite 302, Nashua, NH 03060 Phone: 603-577-3190 Fax: 603-577-3191 |
Dr. John James Janeiro Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 17 Riverside St, Suite 201, Nashua, NH 03062 Phone: 603-594-0800 Fax: 603-879-9329 |
Miguel A Antelo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St, Nashua, NH 03062 Phone: 603-577-3190 Fax: 603-577-3191 |
Dr. Matthew Anthony Stanizzi, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Prospect St, Suite 302, Nashua, NH 03060 Phone: 603-577-3190 Fax: 603-577-3191 |
Morice P. Dennery, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5472 Fax: 603-356-2604 |
News Archive
A new study found no evidence that a commercially available e-cigarette vapor promotes the development of cancer in laboratory cells. In contrast, smoke from a reference cigarette was positive for cancer-promoting activity at very low concentrations.
Video games are quickly becoming a hot topic in cognitive training. Many see them as a potential tool to help patients improve their performance and memory, yet little is known about how different types of video games may affect white matter in the brain and cognition.
The American Society for Gastrointestinal Endoscopy has recognized 48 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States. The ASGE Endoscopy Unit Recognition Program honors endoscopy units that follow the ASGE guidelines on privileging, quality assurance, endoscopy reprocessing and CDC infection control guidelines.
Depomed, Inc. today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceuticals, Inc., for infringement of the patents listed in the Orange Book for GLUMETZA® (metformin hydrochloride extended release tablets).
› Verified 6 days ago